Published in:
Open Access
01-12-2007 | Study protocol
Preoperative biliary drainage for periampullary tumors causing obstructive jaundice; DR ainage vs. (direct) OP eration (DROP-trial)
Authors:
Niels A van der Gaag, Steve MM de Castro, Erik AJ Rauws, Marco J Bruno, Casper HJ van Eijck, Ernst J Kuipers, Josephus JGM Gerritsen, Jan-Paul Rutten, Jan Willem Greve, Erik J Hesselink, Jean HG Klinkenbijl, Inne HM Borel Rinkes, Djamila Boerma, Bert A Bonsing, Cees J van Laarhoven, Frank JGM Kubben, Erwin van der Harst, Meindert N Sosef, Koop Bosscha, Ignace HJT de Hingh, Laurens Th de Wit, Otto M van Delden, Olivier RC Busch, Thomas M van Gulik, Patrick MM Bossuyt, Dirk J Gouma
Published in:
BMC Surgery
|
Issue 1/2007
Login to get access
Abstract
Background
Surgery in patients with obstructive jaundice caused by a periampullary (pancreas, papilla, distal bile duct) tumor is associated with a higher risk of postoperative complications than in non-jaundiced patients. Preoperative biliary drainage was introduced in an attempt to improve the general condition and thus reduce postoperative morbidity and mortality. Early studies showed a reduction in morbidity. However, more recently the focus has shifted towards the negative effects of drainage, such as an increase of infectious complications. Whether biliary drainage should always be performed in jaundiced patients remains controversial. The randomized controlled multicenter DROP-trial (DRainage vs. Operation) was conceived to compare the outcome of a 'preoperative biliary drainage strategy' (standard strategy) with that of an 'early-surgery' strategy, with respect to the incidence of severe complications (primary-outcome measure), hospital stay, number of invasive diagnostic tests, costs, and quality of life.
Methods/design
Patients with obstructive jaundice due to a periampullary tumor, eligible for exploration after staging with CT scan, and scheduled to undergo a "curative" resection, will be randomized to either "early surgical treatment" (within one week) or "preoperative biliary drainage" (for 4 weeks) and subsequent surgical treatment (standard treatment). Primary outcome measure is the percentage of severe complications up to 90 days after surgery. The sample size calculation is based on the equivalence design for the primary outcome measure. If equivalence is found, the comparison of the secondary outcomes will be essential in selecting the preferred strategy. Based on a 40% complication rate for early surgical treatment and 48% for preoperative drainage, equivalence is taken to be demonstrated if the percentage of severe complications with early surgical treatment is not more than 10% higher compared to standard treatment: preoperative biliary drainage. Accounting for a 10% dropout, 105 patients are needed in each arm resulting in a study population of 210 (alpha = 0.95, beta = 0.8).
Discussion
The DROP-trial is a randomized controlled multicenter trial that will provide evidence whether or not preoperative biliary drainage is to be performed in patients with obstructive jaundice due to a periampullary tumor.